To see the other types of publications on this topic, follow the link: ACE-K.
Journal articles on the topic 'ACE-K'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'ACE-K.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
1
Sica, R. J., M. R. M. Izawa, K. A. Walker, C. Boone, S. V. Petelina, P. S. Argall, P. Bernath, et al. "Validation of the Atmospheric Chemistry Experiment (ACE) version 2.2 temperature using ground-based and space-borne measurements." Atmospheric Chemistry and Physics 8, no. 1 (January 8, 2008): 35–62. http://dx.doi.org/10.5194/acp-8-35-2008.
Full textAbstract:
Abstract. An ensemble of space-borne and ground-based instruments has been used to evaluate the quality of the version 2.2 temperature retrievals from the Atmospheric Chemistry Experiment Fourier Transform Spectrometer (ACE-FTS). The agreement of ACE-FTS temperatures with other sensors is typically better than 2 K in the stratosphere and upper troposphere and 5 K in the lower mesosphere. There is evidence of a systematic high bias (roughly 3–6 K) in the ACE-FTS temperatures in the mesosphere, and a possible systematic low bias (roughly 2 K) in ACE-FTS temperatures near 23 km. Some ACE-FTS temperature profiles exhibit unphysical oscillations, a problem fixed in preliminary comparisons with temperatures derived using the next version of the ACE-FTS retrieval software. Though these relatively large oscillations in temperature can be on the order of 10 K in the mesosphere, retrieved volume mixing ratio profiles typically vary by less than a percent or so. Statistical comparisons suggest these oscillations occur in about 10% of the retrieved profiles. Analysis from a set of coincident lidar measurements suggests that the random error in ACE-FTS version 2.2 temperatures has a lower limit of about ±2 K.
2
Sica, R. J., M. R. M. Izawa, K. A. Walker, C. Boone, S. V. Petelina, P. S. Argall, P. Bernath, et al. "Validation of the Atmospheric Chemistry Experiment (ACE) version 2.2 temperature using ground-based and space-borne measurements." Atmospheric Chemistry and Physics Discussions 7, no. 4 (August 23, 2007): 12463–539. http://dx.doi.org/10.5194/acpd-7-12463-2007.
Full textAbstract:
Abstract. An ensemble of space-borne and ground-based instruments has been used to evaluate the quality of the version 2.2 temperature retrievals from the Atmospheric Chemistry Experiment Fourier Transform Spectrometer (ACE-FTS). The agreement of ACE-FTS temperatures with other sensors is typically better than 2 K in the stratosphere and upper troposphere and 5 K in the lower mesosphere. There is evidence of a systematic high bias (roughly 3–6 K) in the ACE-FTS temperatures in the mesosphere, and a possible systematic low bias (roughly 2 K) in ACE-FTS temperatures near 23 km. Some ACE-FTS temperature profiles exhibit unphysical oscillations, a problem fixed in preliminary comparisons with temperatures derived using the next version of the ACE-FTS retrieval software. Though these relatively large oscillations in temperature can be on the order of 10 K in the mesosphere, retrieved volume mixing ratio profiles typically vary by less than a percent or so. Statistical comparisons suggest these oscillations occur in about 10% of the retrieved profiles. Analysis from a set of coincident lidar measurements suggests that the random error in ACE-FTS version 2.2 temperatures has a lower limit of about ±2 K.
3
Bao, Chunju, He Chen, Li Chen, Jili Cao, and Jiangpeng Meng. "Comparison of ACE inhibitory activity in skimmed goat and cow milk hydrolyzed by alcalase, flavourzyme, neutral protease and proteinase K." Acta Universitatis Cibiniensis. Series E: Food Technology 20, no. 1 (June 1, 2016): 77–84. http://dx.doi.org/10.1515/aucft-2016-0006.
Full textAbstract:
Abstract Angiotensin I converting enzyme (ACE) inhibitory peptides derived from milk proteins have obvious effect of lowering blood pressure, safe and non-toxic side effects. This study compared four commercial proteases, namely alcalase, flavourzyme, neutral protease and proteinase K for their ACE inhibitory activity in skimmed goat and cow milk and identified the best one with higher ACE inhibitory activity. The degree of hydrolysis (DH) of alcalase and proteinase K were much higher than flavourzyme, neutral protease for both skimmed goat and cow milk. Alcalase was the best enzyme to produce ACE inhibitory peptides from goat milk, with the ACE inhibitory activity 95.31%, while proteinase K was the optimal protease for hydrolyzing cow milk, with 81.28% ACE inhibitory activity. Furthermore, no correlation was obtained between the ACE inhibitory activity and DH for both goat and cow milk.
4
Zhang, Yanling, Xuechun Wang, Junyan Wu, Bingxiang Wang, Zhaoqiang Zhang, Peng Chen, and Bing Li. "K-001 EFFECT OF ACEI AND AT1 BLOCKADE ON CARDIAC ACE/ACE2 GENE EXPRESSION IN HYDRONEPHROTIC MICE." Journal of Hypertension 29 (November 2011): e34. http://dx.doi.org/10.1097/01.hjh.0000408081.13688.17.
Full text
5
Abdelaal Ahmed Mahmoud, Ahmed, Mark Campbell, and Margarita Blajeva. "Can ACE-I Be a Silent Killer While Normal Renal Functions Falsely Secure Us?" Case Reports in Anesthesiology 2018 (July 9, 2018): 1–4. http://dx.doi.org/10.1155/2018/1852016.
Full textAbstract:
The current case report represents a warning against serious hyperkalaemia and acidosis induced by ACE-I during surgical stress while normal renal function could deceive the attending anaesthetist. Arterial gas analysis for follow-up of haemoglobin loss accidentally discovered hyperkalaemia and acidosis. Glucose-insulin and furosemide successfully corrected hyperkalaemia after 25 minutes and acidosis after 3 hours. These complications could be explained by a deficient steroid stress response to surgery secondary to suppression by ACE-I. Event analysis and database search found that ACE-I induced aldosterone deficiency aggravated by surgical stress response with an inadequate increase in aldosterone secretion due to angiotensin II deficiency as a sequel of ACE-I leading to defective secretion of H+ and K+. Furosemide is recommended to secrete H+ and K+ compensating for aldosterone deficiency in addition to other antihyperkalaemia measures. Anaesthetising an ACE-I treated patient requires considering ACE-I as a potential cause of hyperkalaemia and acidosis.
6
Sun, Min-Ah, Hyun Min Sung, Jisun Kim, Kyung-On Boo, Yoon-Jin Lim, Charline Marzin, and Young-Hwa Byun. "Climate Sensitivity and Feedback of a New Coupled Model (K-ACE) to Idealized CO2 Forcing." Atmosphere 11, no. 11 (November 12, 2020): 1218. http://dx.doi.org/10.3390/atmos11111218.
Full textAbstract:
Climate sensitivity and feedback processes are important for understanding Earth’s system response to increased CO2 concentration in the atmosphere. Many modelling groups that contribute to Coupled Model Intercomparison Project phase 6 (CMIP6) have reported a larger equilibrium climate sensitivity (ECS) with their models compared to CMIP5 models. This consistent result is also found in the Korea Meteorological Administration Advanced Community Earth System model (K-ACE). Idealized climate simulation is conducted as an entry card for CMIP6 to understand Earth’s system response in new coupled models and compared to CMIP5 models. The ECS in the K-ACE is 4.83 K, which is higher than the range (2.1–4.7 K) of CMIP5 models in sensitivity to CO2 change and higher bound (1.8–5.6 K) of CMIP6 models. The radiative feedback consists of clear-sky and cloud radiative feedback. Clear-sky feedback of K-ACE is similar to CMIP5 models whereas cloud feedback of K-ACE is more positive. The result is attributable for strong positive shortwave cloud radiative effect (CRE) feedback associated with reduced low-level cloud cover at mid latitude in both hemispheres. Despite the cancellations in strong negative long wave CRE feedback with the changes in high-level clouds in the tropics, shortwave CRE has a dominant effect in net CRE. Detailed understanding of cloud feedback and cloud properties needs further study.
7
Klein, Janet D., D. Le Quach, Justin M. Cole, Kevin Disher, Anne K. Mongiu, Xiaodan Wang, Kenneth E. Bernstein, and Jeff M. Sands. "Impaired urine concentration and absence of tissue ACE: involvement of medullary transport proteins." American Journal of Physiology-Renal Physiology 283, no. 3 (September 1, 2002): F517—F524. http://dx.doi.org/10.1152/ajprenal.00326.2001.
Full textAbstract:
ACE.2 mice lack all tissue angiotensin-converting enzyme (ACE) but have 33% of normal plasma ACE activity. They exhibit the urine-concentrating defect and hyperkalemia present in mice that lack all ACE, but in contrast to the complete knockout, ACE.2 mice have normal medullary histology and creatinine clearance. To explore the urine-concentrating defect in ACE.2 mice, renal medullary transport proteins were analyzed using Western blot analysis. In the inner medulla, UT-A1, ClC-K1, and aquaporin-1 (AQP1) were significantly reduced to 28 ± 5, 6 ± 6, and 39 ± 5% of the level in wild-type mice, respectively, whereas AQP2 and UT-B were unchanged. In the outer medulla, Na+-K+-2Cl− cotransporter (NKCC2/BSC1) and AQP1 were significantly reduced to 56 ± 11 and 29 ± 6%, respectively, whereas Na+-K+-ATPase, UT-A2, UT-B, and AQP2 were unchanged, and renal outer medullary potassium channel was significantly increased to 711 ± 187% of the level in wild-type mice. The abnormal expression of these transporters was similar in ACE.2 mice backcrossed onto a C57BL/6 or a Swiss background and was not rescued by ANG II infusion. We conclude that the urine-concentrating defect in ACE.2 mice is associated with, and may result from, downregulation of some or all of these key urea, salt, and water transport proteins.
8
Olsen, Kevin S., Geoffrey C. Toon, Chris D. Boone, and Kimberly Strong. "New temperature and pressure retrieval algorithm for high-resolution infrared solar occultation spectroscopy: analysis and validation against ACE-FTS and COSMIC." Atmospheric Measurement Techniques 9, no. 3 (March 15, 2016): 1063–82. http://dx.doi.org/10.5194/amt-9-1063-2016.
Full textAbstract:
Abstract. Motivated by the initial selection of a high-resolution solar occultation Fourier transform spectrometer (FTS) to fly to Mars on the ExoMars Trace Gas Orbiter, we have been developing algorithms for retrieving volume mixing ratio vertical profiles of trace gases, the primary component of which is a new algorithm and software for retrieving vertical profiles of temperature and pressure from the spectra. In contrast to Earth-observing instruments, which can rely on accurate meteorological models, a priori information, and spacecraft position, Mars retrievals require a method with minimal reliance on such data. The temperature and pressure retrieval algorithms developed for this work were evaluated using Earth-observing spectra from the Atmospheric Chemistry Experiment (ACE) FTS, a solar occultation instrument in orbit since 2003, and the basis for the instrument selected for a Mars mission. ACE-FTS makes multiple measurements during an occultation, separated in altitude by 1.5–5 km, and we analyse 10 CO2 vibration–rotation bands at each altitude, each with a different usable altitude range. We describe the algorithms and present results of their application and their comparison to the ACE-FTS data products. The Constellation Observing System for Meteorology, Ionosphere, and Climate (COSMIC) provides vertical profiles of temperature up to 40 km with high vertical resolution. Using six satellites and GPS radio occultation, COSMIC's data product has excellent temporal and spatial coverage, allowing us to find coincident measurements with ACE with very tight criteria: less than 1.5 h and 150 km. We present an intercomparison of temperature profiles retrieved from ACE-FTS using our algorithm, that of the ACE Science Team (v3.5), and from COSMIC. When our retrievals are compared to ACE-FTS v3.5, we find mean differences between −5 and +2 K and that our retrieved profiles have no seasonal or zonal biases but do have a warm bias in the stratosphere and a cold bias in the mesosphere. When compared to COSMIC, we do not observe a warm/cool bias and mean differences are between −4 and +1 K. COSMIC comparisons are restricted to below 40 km, where our retrievals have the best agreement with ACE-FTS v3.5. When comparing ACE-FTS v3.5 to COSMIC we observe a cold bias in COSMIC of 0.5 K, and mean differences are between −0.9 and +0.6 K.
9
Olsen, K. S., G. C. Toon, C. D. Boone, and K. Strong. "New temperature and pressure retrieval algorithm for high-resolution infrared solar occultation spectroscopy: analysis and validation against ACE-FTS and COSMIC." Atmospheric Measurement Techniques Discussions 8, no. 10 (October 23, 2015): 10823–73. http://dx.doi.org/10.5194/amtd-8-10823-2015.
Full textAbstract:
Abstract. Motivated by the initial selection of a high-resolution solar occultation Fourier transform spectrometer (FTS) to fly to Mars on the ExoMars Trace Gas Orbiter, we have been developing algorithms for retrieving volume mixing ratio vertical profiles of trace gases, the primary component of which is a new algorithm and software for retrieving vertical profiles of temperature and pressure from the spectra. In contrast to Earth-observing instruments, which can rely on accurate meteorological models, a priori information, and spacecraft position, Mars retrievals require a method with minimal reliance on such data. The temperature and pressure retrieval algorithms developed for this work were evaluated using Earth-observing spectra from the Atmospheric Chemistry Experiment (ACE) FTS, a solar occultation instrument in orbit since 2003, and the basis for the instrument selected for a Mars mission. ACE-FTS makes multiple measurements during an occultation, separated in altitude by 1.5–5 km, and we analyze 10 CO2 vibration-rotation bands at each altitude, each with a different usable altitude range. We describe the algorithms and present results of their application and their comparison to the ACE-FTS data products. The Constellation Observing System for Meteorology, Ionosphere, and Climate (COSMIC) provides vertical profiles of temperature up to 40 km with high vertical resolution. Using six satellites and GPS radio occultation, COSMIC's data product has excellent temporal and spatial coverage, allowing us to find coincident measurements with ACE with very tight criteria: less than 1.5 h and 150 km. We present an inter-comparison of temperature profiles retrieved from ACE-FTS using our algorithm, that of the ACE Science Team (v3.5), and from COSMIC. When our retrievals are compared to ACE-FTS v3.5, we find mean differences between −5 and +2 K, and that our retrieved profiles have no seasonal or zonal biases, but do have a warm bias in the stratosphere and a cold bias in the mesosphere. When compared to COSMIC, we do not observe a warm/cool bias and mean differences are between −4 and +1 K. COSMIC comparisons are restricted to below 40 km, where our retrievals have the best agreement with ACE-FTS v3.5. When comparing ACE-FTS v3.5 to COSMIC we observe a cold bias in COSMIC of 0.5 K, and mean differences are between −0.9 and +0.6 K.
10
Hool, L. C., D. W. Whalley, M. M. Doohan, and H. H. Rasmussen. "Angiotensin-converting enzyme inhibition, intracellular Na+, and Na(+)-K+ pumping in cardiac myocytes." American Journal of Physiology-Cell Physiology 268, no. 2 (February 1, 1995): C366—C375. http://dx.doi.org/10.1152/ajpcell.1995.268.2.c366.
Full textAbstract:
Angiotensin-converting enzyme (ACE) inhibitors can reduce cardiac mass in both clinical and experimental cardiac hypertrophy. Because cytoplasmic Na+ and pH have been implicated as regulators of cell growth, we examined the effect of treatment with an ACE inhibitor on intracellular Na+ activity (alpha iNa) and pH (pHi) in the heart. After treatment of rabbits with captopril for 8 days alpha iNa was reduced relative to controls (3.6 +/- 0.4, n = 8, vs. 8.2 +/- 0.4 mM, n = 9, P < 0.001), whereas pHi was unchanged. To account for the difference in alpha iNa we measured electrogenic Na(+)-K+ pump activity in single isolated myocytes. Treatment with captopril increased pump currents at near-physiological levels of intracellular Na+ but had no effect at near-saturating levels of Na+. A similar increase in Na(+)-K+ pump activity occurred in rabbits treated with another ACE inhibitor, enalapril, but not with the vasodilator, hydralazine. We speculate that a decrease in alpha iNa after treatment with captopril may contribute to the well-documented ability of ACE inhibitors to reduce cardiac mass.
11
PESKOV, KIRILL, IGOR GORYANIN, KLAUS PRANK, FRANK TOBIN, and OLEG DEMIN. "KINETIC MODELING OFACEOPERON GENETIC REGULATION INESCHERICHIA COLI." Journal of Bioinformatics and Computational Biology 06, no. 05 (October 2008): 933–59. http://dx.doi.org/10.1142/s0219720008003771.
Full textAbstract:
A family of kinetic models has been developed that takes into account available experimental information on the regulation of ace operon expression in Escherichia coli. This has allowed us to study and analyze possible versions of regulation of the ace operon and to test their possibilities. Based on literature analysis, we found that there is an ambiguity of properties of IclR (main repressor of ace operon). The main aspect of this ambiguity are two different forms of IclR purified from E. coli K strain and different coeffector sets for IclR purified from E. coli K and B strains. It has been shown that the full-length form of IclR is physiologically relevant and that IclR truncation is a result of purification of the protein from E. coli K strains. We also found that the IclR protein purified from E. coli B strain carries two coeffector binding sites. Using model-developed levels of steady state aceBAK expression against physiological ranges of coeffectors, concentration has been predicted.
12
Sugita, T., Y. Kasai, Y. Terao, S. Hayashida, G. L. Manney, W. H. Daffer, H. Sagawa, et al. "HCl and ClO profiles inside the Antarctic vortex as observed by SMILES in November 2009: comparisons with MLS and ACE-FTS instruments." Atmospheric Measurement Techniques Discussions 6, no. 4 (July 23, 2013): 6729–65. http://dx.doi.org/10.5194/amtd-6-6729-2013.
Full textAbstract:
Abstract. We present vertical profiles of hydrogen chloride (HCl) and chlorine monoxide (ClO) as observed by the Superconducting Submillimeter-Wave Limb-Emission Sounder (SMILES) inside the Antarctic vortex on 19–24 November 2009. The SMILES HCl value reveals 2.8–3.1 ppbv between 450 and 500 K levels in potential temperature (PT). The high value of HCl is highlighted since it is suggested that HCl was a main component of the total inorganic chlorine (Cly), defined as Cly ≃ HCl + ClO + chlorine nitrate (ClONO2) inside the Antarctic vortex in spring, owing to low ozone values. To confirm the quality of two SMILES Level 2 (L2) data products provided by Japan Aerospace Exploration Agency (JAXA) and National Institute of Information and Communications Technology (NICT) from a view point of the partitioning of Cly, comparisons are made using other satellite data, from the Aura Microwave Limb Sounder (MLS) and Atmospheric Chemistry Experiment Fourier Transform Spectrometer (ACE-FTS). HCl values from the SMILES NICT L2 product agree to within 10% with the MLS HCl data between 425 and 650 K levels in PT and with the ACE-FTS HCl data between 425 and 575 K, respectively. The SMILES JAXA L2 product is 10 to 20% smaller than that from MLS (ACE-FTS) between 400 (500 K) and 700 K. For ClO in daytime, the difference between SMILES (JAXA and NICT) and MLS was less than ±0.05 ppbv between 500 and 650 K with the ClO values less than 0.2 ppbv. ClONO2 values as measured by ACE-FTS also reveal 0.2 ppbv at 475–500 K level, resulting in the HCl/Cly ratios of 0.91–0.95. The high HCl value and HCl/Cly ratio found from the three satellite instruments agree with the past observations inside the Antarctic vortex at this time (October to November) of year in the lower stratosphere.
13
Sugita, T., Y. Kasai, Y. Terao, S. Hayashida, G. L. Manney, W. H. Daffer, H. Sagawa, et al. "HCl and ClO profiles inside the Antarctic vortex as observed by SMILES in November 2009: comparisons with MLS and ACE-FTS instruments." Atmospheric Measurement Techniques 6, no. 11 (November 18, 2013): 3099–113. http://dx.doi.org/10.5194/amt-6-3099-2013.
Full textAbstract:
Abstract. We present vertical profiles of hydrogen chloride (HCl) and chlorine monoxide (ClO) as observed by the Superconducting Submillimeter-Wave Limb-Emission Sounder (SMILES) on the International Space Station (ISS) inside the Antarctic vortex on 19–24 November 2009. The SMILES HCl value reveals 2.8–3.1 ppbv between 450 K and 500 K levels in potential temperature (PT). The high value of HCl is highlighted since it is suggested that HCl is a main component of the total inorganic chlorine (Cly), defined as Cly ≃ HCl + ClO + chlorine nitrate (ClONO2), inside the Antarctic vortex in spring, owing to low ozone values. To confirm the quality of two SMILES level 2 (L2) data products provided by the Japan Aerospace Exploration Agency (JAXA) and Japan's National Institute of Information and Communications Technology (NICT), vis-à-vis the partitioning of Cly, comparisons are made using other satellite data from the Aura Microwave Limb Sounder (MLS) and Atmospheric Chemistry Experiment Fourier Transform Spectrometer (ACE-FTS). HCl values from the SMILES NICT L2 product agree to within 10% (0.3 ppbv) with the MLS HCl data between 450 and 575 K levels in PT and with the ACE-FTS HCl data between 425 and 575 K. The SMILES JAXA L2 product is 10 to 20% (0.2–0.5 ppbv) lower than that from MLS between 400 and 700 K and from ACE-FTS between 500 and 700 K. For ClO in daytime, the difference between SMILES (JAXA and NICT) and MLS is less than ±0.05 ppbv (100 %) between 500 K and 650 K with the ClO values less than 0.2 ppbv. ClONO2 values as measured by ACE-FTS also reveal 0.2 ppbv at 475–500 K level, resulting in the HCl / Cly ratios of 0.91–0.95. The HCl / Cly ratios derived from each retrieval agree to within −5 to 8 % with regard to their averages. The high HCl values and HCl / Cly ratios observed by the three instruments in the lower stratospheric Antarctic vortex are consistent with previous observations in late Austral spring.
14
Cai, Yuan Qi, Jian Bo Cao, Zhi Yun Liu, Shi Ju E, Zhong Yao Wu, and Hong Bo Zhou. "Research on Energy Recovery Damping Device of Vehicle Based on E-ACE." Key Engineering Materials 620 (August 2014): 312–17. http://dx.doi.org/10.4028/www.scientific.net/kem.620.312.
Full textAbstract:
E-ACE (acrylic elastomer) is a kind of material so far in electro-active polymer (EAP) in the most excellent performance. Based on the analysis of the basic principle of the E-ACE power generation, the feasibility is studied on E-ACE power generation principle to achieve energy recovery and damping. Design a model damping device of vehicle for energy recovery based on E-ACE. Through analysis, when the system vibrates near the resonance frequency, deformation of spring is greater, E-ACE materials to move up and down reach the larger amplitude, and the more energy it produces. To analysis the system about harmonic response by ANSYS software, get the relationship between spring stiffness K, damping coefficient C and external incentive, then analysis the resonance frequency of the system. The simulation results verify the feasibility of the design scheme. Results show that E-ACE has excellent performance in the automobile vibration energy recovery and vibration. E-ACE will have broad application prospects.
15
Hool, L. C., D. F. Gray, B. G. Robinson, and H. H. Rasmussen. "Angiotensin-converting enzyme inhibitors regulate the Na(+)-K+ pump via effects on angiotensin metabolism." American Journal of Physiology-Cell Physiology 271, no. 1 (July 1, 1996): C172—C180. http://dx.doi.org/10.1152/ajpcell.1996.271.1.c172.
Full textAbstract:
Treatment of rabbits with angiotensin-converting enzyme (ACE)-inhibiting drugs increases Na(+)-K+ pump current (Ip) of isolated cardiac myocytes when intracellular Na+ is at near-physiological levels. To examine if effects of ACE inhibitors are related to angiotensin metabolism, we measured Ip in myocytes isolated from rabbits treated with the AT1 receptor antagonist losartan. Ip was increased to levels similar to those after treatment with ACE inhibitors. Exposure of myocytes from captopril-treated rabbits to 10 nM angiotensin II (ANG II) for 45 min in vitro reduced Ip to levels similar to those of myocytes from untreated control rabbits. This rapid response to ANG II suggests that treatment with captopril had induced a functional change in preexisting pump units rather than synthesis of a new population of pumps. Consistent with this, we could not detect a change in Na(+)-K+ pump subunit mRNAs during treatment with captopril. The decrease in Ip of myocytes from captopril-treated rabbits induced by ANG II in vitro was blocked by pertussis toxin, bisindolylmaleimide I, and staurosporine. Exposure of myocytes to phorbol 12-myristate 13-acetate induced a decrease in Ip similar to that induced by ANG II. Thus ACE inhibitors regulate the Na(+)-K+ pump in myocytes via an effect on angiotensin metabolism. The regulatory mechanism appears to include the AT1 receptor, a G protein, and protein kinase C.
16
Papapetropoulos, A., L. A. Elmore, and J. D. Catravas. "Relationship between volume of bathing medium and ectoenzyme activity in monolayers of cultured BPAEC." American Journal of Physiology-Lung Cellular and Molecular Physiology 271, no. 3 (September 1, 1996): L464—L469. http://dx.doi.org/10.1152/ajplung.1996.271.3.l464.
Full textAbstract:
It is unclear whether all or a fraction of the capillary plasma volume (Vcp) serves as the reaction volume (Vr) for pulmonary capillary endothelial ectoenzymes, in vivo. Cultured endothelial cell (EC) monolayers provide a convenient model for studying EC-bound enzyme-Vr relationships. Because the Michaelis-Menten parameter [maximum velocity of enzyme reaction (Vmax) = E x kcat/Vr, where E is enzyme mass and kcat is the constant of product formation] is inversely proportional to Vr, we hypothesized that increasing the volume of medium (Vm) bathing EC monolayers would proportionally reduce the calculated Vmax (or Vmax/K(m), where K(m) is the Michaelis constant) values of an ectoenzyme reacting with a substrate only if, and as long as, Vm = Vr. To test this hypothesis, studies were performed in bovine pulmonary arterial EC grown to confluence. Activities of angiotensin-converting enzyme (ACE) and 5'-nucleotidase (NCT) were assayed in Earle's balanced salts solution utilizing [3H]benzoyl-Phe-Ala-Pro ([3H]BPAP) and 5'-[14C]AMP as substrates, respectively. Under first-order reaction conditions and at constant substrate concentrations ([BPAP] = 15 nM, [AMP] = 1 microM), Vmax/K(m) ratios of ACE and NCT declined to 20% of their original values, as Vm increased from 0.6 to 2 ml. ACE activity was also studied at constant substrate mass (BPAP = 7 pmol) under first-order reaction conditions. Again, enzyme activity (Vmax/K(m)) declined proportionally to increasing Vm. Under zero-order reaction conditions ([BPAP] = 250 microM), ACE activity (Vmax) was similarly related to Vm. Linear regression analyses revealed that ACE or NCT would recognize up to at least 3 ml Vm, a volume vastly exceeding that of Vcp in a section of the capillary bed composed of an equivalent number of ECs, thus suggesting that Vcp could serve as the reaction volume for pulmonary capillary EC ectoenzymes in vivo.
17
Ntai, Ioanna, and Brian O. Bachmann. "Identification of ACE pharmacophore in the phosphonopeptide metabolite K-26." Bioorganic & Medicinal Chemistry Letters 18, no. 10 (May 2008): 3068–71. http://dx.doi.org/10.1016/j.bmcl.2007.11.130.
Full text
18
Wooldridge, John M., Frank A. Blazich, and Stuart L. Warren. "Propagation of Eastern Redbud (Cercis canadensis) by Stem Cuttings is Influenced by Clone and Date of Cutting Collection." Journal of Environmental Horticulture 27, no. 2 (June 1, 2009): 109–14. http://dx.doi.org/10.24266/0738-2898-27.2.109.
Full textAbstract:
Abstract Stem cuttings of four popular clones of eastern redbud (Cercis canadensis L. ‘Ace of Hearts’, ‘Appalachian Red’, ‘Hearts of Gold’, and ‘Forest Pansy’) were taken on seven dates following budbreak during Spring and Summer 2007 and evaluated for rooting potential. Rooting was affected by a clone and cutting date interaction, indicating the optimum time to take cuttings was different for each clone. Cuttings of ‘Ace of Hearts’ taken 6 weeks after budbreak (WAB) rooted at 75 and 71% when treated with the potassium (K) salt (K-salt) of indolebutyric acid (K-IBA) at 5000 mg·liter−1 (ppm) or 15,000 mg·liter−1, respectively. In contrast, cuttings of ‘Appalachian Red’ rooted at 96 and 93% when taken 15 WAB, the last date tested for that clone, and treated with K-IBA at 5000 mg·liter−1 or 15,000 mg·liter−1, respectively. When taken 8 WAB and treated with K-IBA at 5000 mg·liter−1 or 15,000 mg·liter−1, cuttings of ‘Hearts of Gold’ rooted at 42 and 58%, respectively. Cuttings of ‘Forest Pansy’ rooted poorly regardless of collection date or K-IBA treatment. Treatment of ‘Ace of Hearts’, ‘Appalachian Red’, and ‘Hearts of Gold’ with higher K-IBA rates generally did not increase rooting percentages, but often resulted in more robust root systems. Propagation by stem cuttings may be feasible for some clones of eastern redbud, but separate protocols are necessary for each clone.
19
Staniloae, Cezar, Andreas J. Schwab, André Simard, Richard Gallo, Ihor Dyrda, Gilbert Gosselin, Jacques Lespérance, James W. Ryan, and Jocelyn Dupuis. "In vivo measurement of coronary circulation angiotensin-converting enzyme activity in humans." American Journal of Physiology-Heart and Circulatory Physiology 284, no. 1 (January 1, 2003): H17—H22. http://dx.doi.org/10.1152/ajpheart.00452.2002.
Full textAbstract:
Angiotensin-converting enzyme (ACE) is present on the luminal surface of the coronary vessels, mostly on capillary endothelium. ACE is also expressed on coronary smooth muscle cells and on plaque lipid-laden macrophages. Excessive coronary circulation (CC)-ACE activity might be linked to plaque progression. Here we used the biologically inactive ACE substrate3H-labeled benzoyl-Phe-Ala-Pro ([3H]BPAP) to quantify CC-ACE activity in 10 patients by means of the indicator-dilution technique. The results were compared with atherosclerotic burden determined by coronary angiography. There was a wide range of CC-ACE activity as revealed by percent [3H]BPAP hydrolysis (30–74%). The atherosclerotic extent scores ranged from 0.0 to 66.97, and the plaque area scores ranged from 0 to 80 mm2. CC-ACE activity per unit extracellular space ( V max/ K m V i), an index of metabolically active vascular surface area, was correlated with myocardial blood flow ( r = 0.738; P = 0.03) but not with measures of the atherosclerotic burden. These results show that CC-ACE activity can be safely measured in humans and that it is a good marker of the vascular area of the perfused myocardium. It does not, however, reflect epicardial atherosclerotic burden, suggesting that local tissue ACE may be more important in plaque development.
20
Zarei, Mohammad, Najib Abidin, Shehu Auwal, Shyan Chay, Zaibunnisa Abdul Haiyee, Adi Md Sikin, and Nazamid Saari. "Angiotensin Converting Enzyme (ACE)-Peptide Interactions: Inhibition Kinetics, In Silico Molecular Docking and Stability Study of Three Novel Peptides Generated from Palm Kernel Cake Proteins." Biomolecules 9, no. 10 (October 4, 2019): 569. http://dx.doi.org/10.3390/biom9100569.
Full textAbstract:
Three novel peptide sequences identified from palm kernel cake (PKC) generated protein hydrolysate including YLLLK, WAFS and GVQEGAGHYALL were used for stability study against angiotensin-converting enzyme (ACE), ACE-inhibition kinetics and molecular docking studies. Results showed that the peptides were degraded at different cleavage degrees of 94%, 67% and 97% for YLLLK, WAFS and GVQEGAGHYALL, respectively, after 3 h of incubation with ACE. YLLLK was found to be the least stable (decreased ACE-inhibitory activity) compared to WAFS and GVQEGAGHYALL (increased ACE-inhibitory activity). YLLLK showed the lowest Ki (1.51 mM) in inhibition kinetics study when compared to WAFS and GVQEGAGHYALL with Ki of 2 mM and 3.18 mM, respectively. In addition, ACE revealed the lowest K m app and V max app and higher catalytic efficiency (CE) in the presence of YLLLK at different concentrations, implying that the enzyme catalysis decreased and hence the inhibition mode increased. Furthermore, YLLLK showed the lowest docking score of −8.224 and seven interactions with tACE, while peptide GVQEGAGHYALL showed the higher docking score of −7.006 and five interactions with tACE.
21
Galbiati, Francesca. "Type IV RTA in Chronic Adrenal Insufficiency and Concomitant Lisinopril Treatment." Case Reports in Endocrinology 2020 (October 19, 2020): 1–3. http://dx.doi.org/10.1155/2020/8897112.
Full textAbstract:
Type IV renal tubular acidosis (RTA) is the only RTA characterized by hyperkalemia, and it is caused by a true aldosterone deficiency or renal tubular aldosterone hyporesponsiveness. It is frequent among hospitalized patients as it is related to type 2 diabetes mellitus (T2DM) and common medications such as ACE-inhibitors (ACE-is) and trimethoprim-sulfamethoxazole (TMP-SMX). Drug-induced RTA commonly manifests in patients with predisposing conditions such as mild renal insufficiency and certain pharmacological therapies. ACE-i use and chronic adrenal insufficiency (cAI) are other significant risk factors. Chronic ACTH suppression is thought to induce global adrenal atrophy, including the zona glomerulosa, thus affecting aldosterone secretion as well. Furthermore, in the setting of cAI, treatment with ACE-is further suppresses aldosterone production. This case report describes a patient with cAI secondary to corticosteroid use for years who developed type IV RTA in the setting of lisinopril use. Potassium (K) elevation persisted despite removing underlying conditions and metabolic acidosis correction. The patient required long-term treatment with mineralocorticoids in addition to sodium bicarbonate to maintain normal K levels and acid-base status. Mineralocorticoid administration is a second-line treatment for type IV RTA, but it might be necessary for a subgroup of high-risk patients. In fact, it is important to consider patients with chronic adrenal insufficiency and on ACE-is treatment at increased risk for refractory hyperkalemia in the setting of type IV RTA. Indeed, this subgroup of patients can have severe hypoaldosteronism.
22
Shao, Qiming, Bin Ren, Vijayan Elimban, Paramjit S. Tappia, Nobuakira Takeda, and Naranjan S. Dhalla. "Modification of sarcolemmal Na+-K+-ATPase and Na+/Ca2+ exchanger expression in heart failure by blockade of renin-angiotensin system." American Journal of Physiology-Heart and Circulatory Physiology 288, no. 6 (June 2005): H2637—H2646. http://dx.doi.org/10.1152/ajpheart.01304.2004.
Full textAbstract:
The activities of both sarcolemmal (SL) Na+-K+-ATPase and Na+/Ca2+ exchanger, which maintain the intracellular cation homeostasis, have been shown to be depressed in heart failure due to myocardial infarction (MI). Because the renin-angiotensin system (RAS) is activated in heart failure, this study tested the hypothesis that attenuation of cardiac SL changes in congestive heart failure (CHF) by angiotensin-converting enzyme (ACE) inhibitors is associated with prevention of alterations in gene expression for SL Na+-K+-ATPase and Na+/Ca2+ exchanger. CHF in rats due to MI was induced by occluding the coronary artery, and 3 wk later the animals were treated with an ACE inhibitor, imidapril (1 mg·kg−1·day−1), for 4 wk. Heart dysfunction and cardiac hypertrophy in the infarcted animals were associated with depressed SL Na+-K+-ATPase and Na+/Ca2+ exchange activities. Protein content and mRNA levels for Na+/Ca2+ exchanger as well as Na+-K+-ATPase α1-, α2- and β1-isoforms were depressed, whereas those for α3-isoform were increased in the failing heart. These changes in SL activities, protein content, and gene expression were attenuated by treating the infarcted animals with imidapril. The beneficial effects of imidapril treatment on heart function and cardiac hypertrophy as well as SL Na+-K+-ATPase and Na+/Ca2+ exchange activities in the infarcted animals were simulated by enalapril, an ACE inhibitor, and losartan, an angiotensin receptor antagonist. These results suggest that blockade of RAS in CHF improves SL Na+-K+-ATPase and Na+/Ca2+ exchange activities in the failing heart by preventing changes in gene expression for SL proteins.
23
Botnaru, Tudor, Antony Robert, and Salvatore Mottillo. "Icatibant Compared to Steroids and Antihistamines for ACE-Inhibitor-Induced Angioedema." CJEM 19, no. 2 (May 18, 2016): 159–62. http://dx.doi.org/10.1017/cem.2016.21.
Full text
24
Kasi, Vijaykumar S., Hong D. Xiao, Lijuan L. Shang, Shahriar Iravanian, Jonathan Langberg, Emily A. Witham, Zhe Jiao, Carlos J. Gallego, Kenneth E. Bernstein, and Samuel C. Dudley. "Cardiac-restricted angiotensin-converting enzyme overexpression causes conduction defects and connexin dysregulation." American Journal of Physiology-Heart and Circulatory Physiology 293, no. 1 (July 2007): H182—H192. http://dx.doi.org/10.1152/ajpheart.00684.2006.
Full textAbstract:
Renin-angiotensin (RAS) system activation is associated with an increased risk of sudden death. Previously, we used cardiac-restricted angiotensin-converting enzyme (ACE) overexpression to construct a mouse model of RAS activation. These ACE 8/8 mice die prematurely and abruptly. Here, we have investigated cardiac electrophysiological abnormalities that may contribute to early mortality in this model. In ACE 8/8 mice, surface ECG voltages are reduced. Intracardiac electrograms showed atrial and ventricular potential amplitudes of 11% and 24% compared with matched wild-type (WT) controls. The atrioventricular (AV), atrio-Hisian (AH), and Hisian-ventricular (HV) intervals were prolonged 2.8-, 2.6-, and 3.9-fold, respectively, in ACE 8/8 vs. WT mice. Various degrees of AV nodal block were present only in ACE 8/8 mice. Intracardiac electrophysiology studies demonstrated that WT and heterozygote (HZ) mice were noninducible, whereas 83% of ACE 8/8 mice demonstrated ventricular tachycardia with burst pacing. Atrial connexin 40 (Cx40) and connexin 43 (Cx43) protein levels, ventricular Cx43 protein level, atrial and ventricular Cx40 mRNA abundances, ventricular Cx43 mRNA abundance, and atrial and ventricular cardiac Na+ channel (Scn5a) mRNA abundances were reduced in ACE 8/8 compared with WT mice. ACE 8/8 mice demonstrated ventricular Cx43 dephosphorylation. Atrial and ventricular L-type Ca2+ channel, Kv4.2 K+ channel α-subunit, and Cx45 mRNA abundances and the peak ventricular Na+ current did not differ between the groups. In isolated heart preparations, a connexin blocker, 1-heptanol (0.5 mM), produced an electrophysiological phenotype similar to that seen in ACE 8/8 mice. Therefore, cardiac-specific ACE overexpression resulted in changes in connexins consistent with the phenotype of low-voltage electrical activity, conduction defects, and induced ventricular arrhythmia. These results may help explain the increased risk of arrhythmia in states of RAS activation such as heart failure.
25
Peng, Chiung-Huei, Mon-Yuan Yang, Yi-Sun Yang, Chieh-Chou Yu, and Chau-Jong Wang. "Antrodia cinnamomea Prevents Obesity, Dyslipidemia, and the Derived Fatty Liver via Regulating AMPK and SREBP Signaling." American Journal of Chinese Medicine 45, no. 01 (January 2017): 67–83. http://dx.doi.org/10.1142/s0192415x17500069.
Full textAbstract:
Antrodia cinnamomea (AC), a protogenic fungus that only grows on the heartwood of endemic Cinnamomum kanehirae Hayata in Taiwan, is used to treat a variety of illness including liver disease. However, little is known about the benefit of AC against obesity and the related hepatic disorder. Using high-fat-diet (HFD) feed mice, we aimed to investigate whether the extract of AC (ACE) could reduce excessive weight, body fat, and serum lipids and prevent the development of non-alcoholic fatty liver (NAFLD). C57BL/6 mice were divided into five groups fed with different diets: control, HFD, and HFD with 0.5%, 1%, or 2% of ACE, respectively. After 10 weeks the animals were sacrificed, with serum and liver collected. HFD-induced elevation of body weight gain, body fat deposition, and serum free fatty acid (FFA), triacylglycerol (TGs), total cholesterol, and ratio of LDL cholesterol (LDL-C)/HDL cholesterol (HDL-C), were significantly restored by ACE. ACE reduced aspartate aminotransferase (AST), alanine aminotransferase (ALT), and hepatic lipid deposits increased by HFD. ACE increased p-AMP activated protein kinase (pAMPK) but decreased Sterol regulatory element binding protein (SREBP), fatty acid synthase (FAS), 1-acylglycerol-3-phosphate acyltransferase (AGPAT), and 3-hydroxy-3-methylglutaryl-coenzyme A (HMGCoA) reductase. The chemical analysis reveals ACE is full of triterpenes, the most abundant of which is Antcin K, followed by sulphurenic acid, eburicoic acid, antcin C, dehydrosulphurenic acid, antcin B, and propanoic acid. In conclusion, ACE should be used to prevent obesity and derived fatty liver. The applicability of ACE on NAFLD deserves further investigation.
26
Ha, Eun Ju, Jung Hee Shin, Dong Gyu Na, So Lyung Jung, Young Hen Lee, Wooyul Paik, Min Ji Hong, Yeo Koon Kim, and Chang Yoon Lee. "Comparison of the diagnostic performance of the modified Korean Thyroid Imaging Reporting and Data System for thyroid malignancy with three international guidelines." Ultrasonography 40, no. 4 (October 1, 2021): 594–601. http://dx.doi.org/10.14366/usg.21056.
Full textAbstract:
Purpose: This study compared the diagnostic performance of the modified Korean Thyroid Imaging Reporting and Data System (K-TIRADS) for thyroid malignancy with three international guidelines.Methods: From June to September 2015, 5,708 thyroid nodules (≥1.0 cm) in 5,081 consecutive patients who underwent thyroid ultrasound (US) at 26 institutions were evaluated. The US features of the thyroid nodules were retrospectively reviewed and classified according to all four guidelines. In the modified K-TIRADS, the biopsy size threshold was changed to 2.0 cm for K-TIRADS 3 and 1.0 or 1.5 cm for K-TIRADS 4 (K-TIRADS1.0cm and K-TIRADS1.5cm, respectively). We compared the diagnostic performance and unnecessary fine-needle aspiration biopsy (FNAB) rates for thyroid malignancy between the modified K-TIRADS and three international guidelines.Results: Of the 5,708 thyroid nodules, 4,597 (80.5%) were benign and 1,111 (19.5%) were malignant. The overall sensitivity was highest for the modified K-TIRADS1.0cm (91.0%), followed by the European (EU)-TIRADS (84.6%), American Association of Clinical Endocrinologists/American College of Endocrinology/Associazione Medici Endocrinologi (AACE/ACE/AME) (80.5%), American College of Radiology (ACR)-TIRADS (76.1%), and modified K-TIRADS1.5cm (76.1%). For large nodules (>2.0 cm), the sensitivity increased to 98.0% in both the modified K-TIRADS1.0cm and K-TIRADS1.5cm. For small nodules (≤2.0 cm), the unnecessary FNAB rate was lowest with the modified K-TIRADS1.5cm (17.6%), followed by the ACR-TIRADS (18.6%), AACE/ACE/AME (19.3%), EU-TIRADS (28.1%), and modified K-TIRADS1.0cm (31.2%).Conclusion: The modified K-TIRADS1.5cm can reduce the unnecessary FNAB rate for small nodules (1.0-2.0 cm), while maintaining high sensitivity for detecting malignancies >2.0 cm.
27
Jasrotia, Raman, Jyotdeep K. Raina, Minakshee Sharma, Rakesh K. Panjaliya, B. R. Kundal, and Parvinder Kumar. "Relationship of MTHFR and ACE gene Variations with Migraine Susceptibility: A Case-Control Study in the Population of North India (Jammu)." Biosciences Biotechnology Research Asia 15, no. 4 (December 28, 2018): 851–60. http://dx.doi.org/10.13005/bbra/2694.
Full textAbstract:
Disturbance in vascular functioning pathways has been related to pathophysiology of migraine. The present study investigated the role of MTHFR C677T and ACE I/D gene polymorphisms in migraine susceptibility within the population of Jammu province of J&K state. A sum of 252 subjects including 102 migraine patients and 150 non-migrainous unrelated healthy controls were enrolled for the present study. PCR-RFLP was performed for determining MTHFR gene variations. For detecting insertion/deletion in ACE gene PCR was performed. In case of MTHFR, ‘T’ allele (variant allele) and TT genotype (variant) was found to be present only in migraine patients but not in controls thereby suggesting its positive role in migraine pathophysiology. For ACE I/D polymorphism, higher frequency of DD genotype (32.35 % vs 15.3 %) and D allele (0.51 vs 0.4) were observed in patients than in controls. Logistic regression analysis revealed a significant association of ACE I/D polymorphism with risk of migraine. However, a direct link of MTHFR C677T polymorphism with migraine risk was not found.
28
Lindberg, B. F., L. G. Nilsson, H. Hedlund, M. Stahl, and K. E. Andersson. "Angiotensin I is converted to angiotensin II by a serine protease in human detrusor smooth muscle." American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 266, no. 6 (June 1, 1994): R1861—R1867. http://dx.doi.org/10.1152/ajpregu.1994.266.6.r1861.
Full textAbstract:
The aim of the present study was to investigate whether a pathway for conversion of angiotensin I (ANG I) to angiotensin II (ANG II) other than that via angiotensin-converting enzyme (ACE) is present in the smooth muscle of the human detrusor. Isolated detrusor strips from 11 patients were contracted by ANG I (1 microM) in the absence or presence of enalaprilat (10 microM), soybean trypsin inhibitor (STI, 200 micrograms/ml), or both. The metabolic activity in detrusor membranes from four patients was studied separately using Hip-Gly-Gly or ANG I as a substrate, with or without various protease inhibitors. The contractile response to ANG I (1 microM) was depressed by enalaprilat from 66 +/- 22 (mean +/- SD) to 39 +/- 13% of the K+ (124 mM)-induced response (P < 0.01, n = 11), and the combination of enalaprilat and STI resulted in a further reduction in contractile amplitude to 25 +/- 14% (P < 0.01 vs. K+, and P < 0.05 vs. enalaprilat alone) and a significantly slower developing contraction with a time to peak of 3.7 +/- 1.7 vs. 1.1 +/- 0.3 min for ANG I alone (P < 0.01). In detrusor membranes, a low ACE activity, inhibitable by captopril, was demonstrated by the formation of hippuric acid (0.70 nmol.min-1.mg protein-1) from the synthetic ACE substrate, Hip-Gly-Gly. However, the conversion of ANG I (166 nmol.min-1.mg protein-1) to ANG II was not affected by ACE inhibition, while serine protease inhibitors, e.g., STI and chymostatin, completely prevented ANG II formation.(ABSTRACT TRUNCATED AT 250 WORDS)
29
Abubakar, Amhar. "Isolasi Penghambat Aktivitas Enzim Pengubah Angiotensin Dari Protein Susu." Jurnal Agripet 7, no. 2 (March 24, 2016): 33–38. http://dx.doi.org/10.17969/agripet.v7i2.3212.
Full textAbstract:
ABSTRACT. Three kinds of samles (whey protein containing casenoglycopeptide, whey protein removed casenoglycopeptide and cheese whey powder digested with 7 kinds of proteases at 37 0C for 24 hr (trypsin, protenase-K, actinase-E, thermolysin, and papain) or 25 0C (pepsin and chymotrypsin). Strong inhibotory activity against the angiotensin converting enzyime (ACE, EC 3.4.15.1) was generated in all samples by 5 proteases digestion (pepsin, chymotrypsin, protinase-K, thermolysin and papain). In whey protein removed caseinoglycopeptide digestion by thermolysin induced the highest activity (95,25%). In cheese whey powder, the highest activity was derived by thermolysin (98.25%). On the other hand, week ACE inhibitory activity were derived by trypsin and actinase-E digestion. As no remarkable differences in inhibitory activity were observed between whey protein containing casenoglycopeptide and whey protein removed casenoglycopeptide samples, the bioactive peptides are considered to come mainly not from casenoglycopeptide but from cheese whey powder components.
30
Lee, Johan, Jisun Kim, Min-Ah Sun, Byeong-Hyeon Kim, Hyejin Moon, Hyun Min Sung, Jinwon Kim, and Young-Hwa Byun. "Evaluation of the Korea Meteorological Administration Advanced Community Earth-System model (K-ACE)." Asia-Pacific Journal of Atmospheric Sciences 56, no. 3 (August 26, 2019): 381–95. http://dx.doi.org/10.1007/s13143-019-00144-7.
Full text
31
Mahmud, Rizwan, Saadlee Shehreen, Shayan Shahriar, Md Siddiqur Rahman, Sharif Akhteruzzaman, and Abu Ashfaqur Sajib. "Non-Caloric Artificial Sweeteners Modulate the Expression of Key Metabolic Genes in the Omnipresent Gut Microbe Escherichia coli." Journal of Molecular Microbiology and Biotechnology 29, no. 1-6 (2019): 43–56. http://dx.doi.org/10.1159/000504511.
Full textAbstract:
The human gut is inhabited by several hundred different bacterial species. These bacteria are closely associated with our health and well-being. The composition of these diverse commensals is influenced by our dietary intakes. Non-caloric artificial sweeteners (NAS) have gained global popularity, particularly among diabetic patients, due to their perceived health benefits, such as reduction of body weight and maintenance of blood glucose level compared to caloric sugars. Recent studies have reported that these artificial sweeteners can alter the composition of gut microbiota and, thus, affect our normal physiological state. Here, we investigated the effect of aspartame and acesulfame potassium (ace-K), two popular NAS, in a commercial formulation on the growth and metabolic pathways of omnipresent gut commensal <i>Escherichia coli</i>by analyzing the relative expression levels of the key genes, which control over twenty important metabolic pathways. Treatment with NAS preparation (aspartame and ace-K) modulates the growth of <i>E. coli</i>as well as inducing the expression of important metabolic genes associated with glucose (<i>pfkA, sucA, aceE, pfkB, lpdA</i>), nucleotide (<i>tmk, adk, tdk, thyA</i>), and fatty acid (<i>fabI</i>) metabolisms, among others. Several of the affected genes<b><i></i></b>were previously reported to be important for the colonization of the microbes in the gut. These findings may shed light on the mechanism of alteration of gut microbes and their metabolism by NAS.
32
Orfanos, Stylianos E., James B. Parkerson, Xilin Chen, Eugene L. Fisher, Constantinos Glynos, Andreas Papapetropoulos, Ross G. Gerrity, and John D. Catravas. "Reduced lung endothelial angiotensin-converting enzyme activity in Watanabe hyperlipidemic rabbits in vivo." American Journal of Physiology-Lung Cellular and Molecular Physiology 278, no. 6 (June 1, 2000): L1280—L1288. http://dx.doi.org/10.1152/ajplung.2000.278.6.l1280.
Full textAbstract:
We investigated pulmonary endothelial function in vivo in 12- to 18-mo-old male Watanabe heritable hyperlipidemic (WHHL; n = 7) and age- and sex-matched New Zealand White ( n = 8) rabbits. The animals were anesthetized and artificially ventilated, and the chest was opened and put in total heart bypass. The single-pass transpulmonary utilizations of the angiotensin-converting enzyme (ACE) substrate [3H]benzoyl-Phe-Ala-Pro (BPAP) and the 5′-nucleotidase (NCT) substrate [14C]AMP were estimated, and the first-order reaction parameter A max/ K m, where A max is the product of enzyme mass and the catalytic rate constant and K m is the Michaelis-Menten constant, was calculated. BPAP transpulmonary utilization and A max/ K m were reduced in WHHL (1.69 ± 0.16 vs. 2.9 ± 0.44 and 599 ± 69 vs. 987 ± 153 ml/min in WHHL and control rabbits, respectively; P < 0.05 for both). No differences were observed in the AMP parameters. BPAP K m and A max values were estimated separately under mixed-order reaction conditions. No differences in K m values were found (9.79 ± 1 vs. 9.9 ± 1.31 μM), whereas WHHL rabbit A max was significantly decreased (5.29 ± 0.88 vs. 7.93 ± 0.8 μmol/min in WHHL and control rabbits, respectively; P < 0.05). We conclude that the observed pulmonary endothelial ACE activity reduction in WHHL rabbits appears related to a decrease in enzyme mass rather than to alterations in enzyme affinity.
33
Rocha, Maria Sheila Guimarães, Elida Maria Bassetti, Maira Okada Oliveira, Nathercia Marinho Estevam, and Sonia Maria Dozzi Brucki. "Addenbrooke's Cognitive Examination-Revised is accurate for detecting dementia in Parkinson's disease patients with low educational level." Dementia & Neuropsychologia 8, no. 1 (March 2014): 20–25. http://dx.doi.org/10.1590/s1980-57642014dn81000004.
Full textAbstract:
ABSTRACT Diagnosis of Parkinson's disease dementia is a challenge in clinical settings. A comprehensive neuropsychological evaluation is time-consuming and expensive; brief instruments for cognitive evaluation must be easier to administer and provide a reliable classification. Objective: To study the validity of the Brazilian version of Addenbrooke's Cognitive Examination-Revised (ACE-R) for the cognitive assessment of Parkinson's disease (PD) patients with heterogeneous educational level. Methods: Patients were evaluated according to the diagnostic procedures recommended by the Movement Disorder Society (MDS) as the gold standard for the diagnosis of dementia in PD. Results: We studied 70 idiopathic PD patients, with a mean (SD) age of 64.1 (9.3) years and mean disease duration of 7.7 (5.3) years and educational level of 5.9 years, matched for education and age to controls. Twenty-seven patients fulfilled MDS clinical criteria for PD dementia. Mean scores on the ACE-R were 54.7 (12.8) points for patients with PD dementia, 76 (9.9) for PD patients without dementia and 79.7 (1.8) points for healthy controls. The area under the receiver operating curve, taking the MDS diagnostic procedures as a reference, was 0.93 [95% CI, 0.87-0.98; p<0.001] for ACE-R. The optimal cut-off value for ACE-R was ≤72 points [sensitivity 90%; specificity 85%; Kappa concordance (K) 0.79]. Conclusion: ACE-R appears to be a valid tool for dementia evaluation in PD patients with heterogeneous educational level, displaying good correlation with clinical criteria and diagnostic procedures of the MDS.
34
OLIVEIRA, ANIBAL R., DANIELA F. S. RODRIGUES, and CARLOS H. W. FLECHTMANN. "A new eriophyoid mite genus and species, Gymnaceria cupuassu (Acari: Eriophyidae), described from the cupuaçu tree in Brazil." Zootaxa 3559, no. 1 (November 22, 2012): 53. http://dx.doi.org/10.11646/zootaxa.3559.1.5.
Full textAbstract:
A new eriophyoid mite genus and species, Gymnaceria cupuassu n. sp. et n. gen. (Acari: Eriophyidae: Eriophyinae: Ace-riini), is described from young fruits and other plant parts of the cupuaçu tree, Theobroma grandiflorum (Willd. Ex Spreng.) K. Schum. (Sterculiaceae), from the State of Bahia, northeastern Brazil. No visible damage symptoms were observed.
35
Zamzam, Nada S., Mona H. Abdel Rahman, and Maha F. Abdel Ghani. "Environmentally Evaluated New HPLC/UV Method for the Simultaneous Determination of Acesulfame-K, Butylated Hydroxytoluene, and Aspartame and Its Degradant in Chewing Gum." Journal of AOAC International 102, no. 6 (November 1, 2019): 1892–900. http://dx.doi.org/10.5740/jaoacint.19-0037.
Full textAbstract:
Background: Acesulfame-K (ACE), butylated hydroxytoluene (BHT), and aspartame (ASP) are a common combination of food additives added to chewing gums. The abuse of these additives results in severe adverse health effects; however, they are still extensively used owing to their high performance and low cost. Objective: The development and optimization of a simple, cheap, sensitive, and eco-friendly HPLC/UV method for the simultaneous determination of ASP, ACE, and BHT along with aspartame degradation product phenylalanine (PHEN) in chewing gum. Methods: The method was optimized using a 5 μm C18 column and an eluent consisting of methanol and 0.1 M phosphate buffer (pH 5.0) according to a suitable gradient elution program. Simple sample preparation, consisting of dilution, homogenization, and sonication followed by centrifugation and filtration, was optimized and used for the extraction of chewing gum. The greenness of the method was evaluated. Results: The proposed method exhibited excellent linearity (R2 > 0.9996), low LOQ (0.08–0.95 μg/mL), and recoveries between 85.3 and 98.83% with relative SD (RSD) ≤ 2.7%. High resolution was obtained with <25 min run times with excellent precision (RSD: 0.28–1.33%). This method was successfully applied for the simultaneous determination of ACE, ASP, and BHT in commercial chewing gum; PHEN was not detected. Furthermore, our method is considered to be environmentally acceptable. Conclusions: The results demonstrate that the developed method can be used to detect ACE, BHT, ASP, and PHEN in chewing gum. Highlights: A new sensitive, green HPLC/UV method is developed to be used as a minimal-cost routine analysis procedure for commercial chewing gum.
36
Bigot, Antony, Michèle Bois-Choussy, and Jieping Zhu. "An efficient total synthesis of K-13, a non-competitive inhibitor of ACE I." Tetrahedron Letters 41, no. 23 (June 2000): 4573–77. http://dx.doi.org/10.1016/s0040-4039(00)00695-x.
Full text
37
García-Comas, M., B. Funke, A. Gardini, M. López-Puertas, A. Jurado-Navarro, T. von Clarmann, G. Stiller, et al. "MIPAS temperature from the stratosphere to the lower thermosphere: Comparison of vM21 with ACE-FTS, MLS, OSIRIS, SABER, SOFIE and lidar measurements." Atmospheric Measurement Techniques 7, no. 11 (November 6, 2014): 3633–51. http://dx.doi.org/10.5194/amt-7-3633-2014.
Full textAbstract:
Abstract. We present vM21 MIPAS temperatures from the lower stratosphere to the lower thermosphere, which cover all optimized resolution measurements performed by MIPAS in the middle-atmosphere, upper-atmosphere and noctilucent-cloud modes during its lifetime, i.e., from January 2005 to April 2012. The main upgrades with respect to the previous version of MIPAS temperatures (vM11) are the update of the spectroscopic database, the use of a different climatology of atomic oxygen and carbon dioxide, and the improvement in important technical aspects of the retrieval setup (temperature gradient along the line of sight and offset regularizations, apodization accuracy). Additionally, an updated version of ESA-calibrated L1b spectra (5.02/5.06) is used. The vM21 temperatures correct the main systematic errors of the previous version because they provide on average a 1–2 K warmer stratopause and middle mesosphere, and a 6–10 K colder mesopause (except in high-latitude summers) and lower thermosphere. These lead to a remarkable improvement in MIPAS comparisons with ACE-FTS, MLS, OSIRIS, SABER, SOFIE and the two Rayleigh lidars at Mauna Loa and Table Mountain, which, with a few specific exceptions, typically exhibit differences smaller than 1 K below 50 km and than 2 K at 50–80 km in spring, autumn and winter at all latitudes, and summer at low to midlatitudes. Differences in the high-latitude summers are typically smaller than 1 K below 50 km, smaller than 2 K at 50–65 km and 5 K at 65–80 km. Differences between MIPAS and the other instruments in the mid-mesosphere are generally negative. MIPAS mesopause is within 4 K of the other instruments measurements, except in the high-latitude summers, when it is within 5–10 K, being warmer there than SABER, MLS and OSIRIS and colder than ACE-FTS and SOFIE. The agreement in the lower thermosphere is typically better than 5 K, except for high latitudes during spring and summer, when MIPAS usually exhibits larger vertical gradients.
38
García-Comas, M., B. Funke, A. Gardini, M. López-Puertas, A. Jurado-Navarro, T. von Clarmann, G. Stiller, et al. "MIPAS temperature from the stratosphere to the lower thermosphere: comparison of version vM21 with ACE-FTS, MLS, OSIRIS, SABER, SOFIE and lidar measurements." Atmospheric Measurement Techniques Discussions 7, no. 7 (July 4, 2014): 6651–97. http://dx.doi.org/10.5194/amtd-7-6651-2014.
Full textAbstract:
Abstract. We present vM21 MIPAS temperatures from the lower stratosphere to the lower thermosphere, which cover all optimized resolution measurements performed by MIPAS in the Middle Atmosphere, Upper Atmosphere and NoctiLucent Cloud modes during its lifetime. i.e., from January 2005 to March 2012. The main upgrades with respect to the previous version of MIPAS temperatures (vM11) are the update of the spectroscopic database, the use of a different climatology of atomic oxygen and carbon dioxide, and the improvement of important technical aspects of the retrieval setup (temperature gradient along the line of sight and offset regularizations, apodization accuracy). Additionally, an updated version of ESA calibrated L1b spectra (5.02/5.06) is used. The vM21 temperatures correct the main systematic errors of the previous version because they on average provide a 1–2 K warmer stratopause and middle mesosphere, and a 6–10 K colder mesopause (except in high latitude summers) and lower thermosphere. These lead to a remarkable improvement of MIPAS comparisons with ACE-FTS, MLS, OSIRIS, SABER, SOFIE and the two Rayleigh lidars at Mauna Loa and Table Mountain, that, with few specific exceptions, typically exhibit differences smaller than 1 K below 50 km and than 2 K at 50–80 km in spring, autumn, winter at all latitudes, and summer at low to mid-latitudes. Differences in the high latitude summers are typically smaller than 1 K below 50 km, smaller than 2 K at 50–65 km and 5 K at 65–80 km. Differences with the other instruments in the mid-mesosphere are generally negative. MIPAS mesopause is within 4 K of the other instruments measurements, except in the high latitude summers, where it is within 5–10 K of the other instruments, being warmer than SABER, MLS and OSIRIS and colder than ACE-FTS and SOFIE. The agreement in the lower thermosphere is typically better than 5 K, except for high latitudes during spring and summer, where MIPAS usually exhibits larger vertical gradients.
39
Cheng, Cailan L., Ying Tang, Zhenda Zheng, Xun Liu, Zengchun C. Ye, Cheng Wang, and Tanqi Q. Lou. "Advanced glycation end-products activate the renin-angiotensin system through the RAGE/PI3-K signaling pathway in podocytes." Clinical & Investigative Medicine 35, no. 5 (October 6, 2012): 282. http://dx.doi.org/10.25011/cim.v35i5.18701.
Full textAbstract:
Purpose: The purpose of this study was to investigate the effects of advanced glycation end-products (AGEs) on the components of the renin-angiotensin system (RAS) in podocytes and to understand the mechanism of these effects. Methods: Immortalized mouse podocytes were exposed to various concentrations of AGEs for different time intervals. The expression levels of angiotensinogen (AGT), angiotensin II type 1 and 2 receptors (AT1R and AT2R) and renin were examined by real-time PCR and western blot; the receptor for AGEs (RAGE) and both Akt and phosphorylated Akt were examined by western blot; levels of angiotensin II (Ang II) were assayed by ELISA, and the activity of angiotensin-converting enzyme (ACE) was evaluated by measuring the production of hippuric acid in vitro. Results: Treatment with AGEs resulted in significant increases in the expression of AGT (62%, P=0.002) and AT1R (59%, P=0.01). Moreover, Ang II levels increased significantly in both cell lysates (70%, P=0.018) and conditioned media (65%, P=0.01). ACE activity was also significantly higher in cell lysates (68% , P= 0.035) and conditioned media (65%, P=0.023). There were no changes in renin or AT2R expression (P > 0.05). AGEs did increase the expression of RAGE by 50% (P=0.012) and the phosphorylation of Akt by 100% (P=0.001). When podocytes were pretreated with anti-RAGE antibody (50 µg/ml) or the phosphoinositide 3-kinase (PI3-K) inhibitor, LY294002 (10 µM), the AGEs-induced increases in AGT and AT1R expression were reduced. Likewise, Ang II levels and ACE activity decreased significantly. Conclusion: AGEs activate the RAS in podocytes through the RAGE-PI3-K/Akt-dependent pathway and lead to an increase in podocyte apoptosis.
40
Rudi, Wolf-Stephan, Michael Molitor, Venkata Garlapati, Stefanie Finger, Johannes Wild, Thomas Münzel, Susanne H. Karbach, and Philip Wenzel. "ACE Inhibition Modulates Myeloid Hematopoiesis after Acute Myocardial Infarction and Reduces Cardiac and Vascular Inflammation in Ischemic Heart Failure." Antioxidants 10, no. 3 (March 5, 2021): 396. http://dx.doi.org/10.3390/antiox10030396.
Full textAbstract:
Aims: Angiotensin-converting-enzyme inhibitors (ACE inhibitors) are a cornerstone of drug therapy after myocardial infarction (MI) and improve left ventricular function and survival. We aimed to elucidate the impact of early treatment with the ACE inhibitor ramipril on the hematopoietic response after MI, as well as on the chronic systemic and vascular inflammation. Methods and Results: In a mouse model of MI, induced by permanent ligation of the left anterior descending artery, immediate initiation of treatment with ramipril (10 mg/k/d via drinking water) reduced cardiac inflammation and the number of circulating inflammatory monocytes, whereas left ventricular function was not altered significantly, respectively. This effect was accompanied by enhanced retention of hematopoietic stem cells, Lin−Sca1−c-Kit+CD34+CD16/32+ granulocyte–macrophage progenitors (GMP) and Lin−Sca1−c-Kit+CD150−CD48− multipotent progenitors (MPP) in the bone marrow, with an upregulation of the niche factors Angiopoetin 1 and Kitl at 7 d post MI. Long-term ACE inhibition for 28 d limited vascular inflammation, particularly the infiltration of Ly6Chigh monocytes/macrophages, and reduced superoxide formation, resulting in improved endothelial function in mice with ischemic heart failure. Conclusion: ACE inhibition modulates the myeloid inflammatory response after MI due to the retention of myeloid precursor cells in their bone marrow reservoir. This results in a reduction in cardiac and vascular inflammation with improvement in survival after MI.
41
Shamova, O. V., D. S. Orlov, S. V. Balandin, E. I. Shramova, E. V. Tsvetkova, P. V. Panteleev, Yu F. Leonova, A. A. Tagaev, V. N. Kokryakov, and T. V. Ovchinnikova. "Acipensins - Novel Antimicrobial Peptides from Leukocytes of the Russian Sturgeon Acipenser gueldenstaedtii." Acta Naturae 6, no. 4 (December 15, 2014): 99–109. http://dx.doi.org/10.32607/20758251-2014-6-4-99-109.
Full textAbstract:
Antimicrobial peptides (AMPs) play an important role in the innate defense mechanisms in humans and animals. We have isolated and studied a set of antimicrobial peptides from leukocytes of the Russian sturgeon Acipenser gueldenstaedtii belonging to a subclass of chondrosteans, an ancient group of bony fish. Structural analysis of the isolated peptides, designated as acipensins (Ac), revealed in leukocytes of the Russian sturgeon six novel peptides with molecular masses of 5336.2 Da, 3803.0 Da, 5173.0 Da, 4777.5 Da, 5449.4 Da, and 2740.2 Da, designated as Ac1-Ac6, respectively. Complete primary structures of all the isolated peptides were determined, and the biological activities of three major components - Ac1, Ac2, and Ac6 - were examined. The peptides Ас1, Ас2, Ас3, Ас4, and Ac5 were found to be the N-terminal acetylated fragments 1-50, 1-35, 1-49, 1-44, and 1-51 of the histone Н2А, respectively, while Ас6 was shown to be the 62-85 fragment of the histone Н2А. The peptides Ac1 and Ac2 displayed potent antimicrobial activity towards Gram-negative and Gram-positive bacteria (Escherichia coli ML35p, Listeria monocytogenes EGD, MRSA ATCC 33591) and the fungus Candida albicans 820, while Ac6 proved effective only against Gram-negative bacteria. The efficacy of Ac 1 and Ac2 towards the fungus and MRSA was reduced upon an increase in the ionic strength of the solution. Ac1, Ac2, and Ac6, at concentrations close to their minimum inhibitory concentrations, enhanced the permeability of the E.coli ML35p outer membrane to the chromogenic marker, but they did not affect appreciably the permeability of the bacterial inner membrane in comparison with a potent pore-forming peptide, protegrin 1. Ac1, Ac2, and Ac6 revealed no hemolytic activity against human erythrocytes at concentrations of 1 to 40 M and had no cytotoxic effect (1 to 20 M) on K-562 and U-937 cells in vitro. Our findings suggest that histone-derived peptides serve as important anti-infective host defense molecules.
42
Zamzam, Nada S., Mona H. Abdel Rahman, and Maha F. Abdel Ghani. "Environmentally Evaluated New HPLC/UV Method for the Simultaneous Determination of Acesulfame-K, Butylated Hydroxytoluene, and Aspartame and Its Degradant in Chewing Gum." Journal of AOAC INTERNATIONAL 102, no. 6 (November 1, 2019): 1892–900. http://dx.doi.org/10.1093/jaoac/102.6.1892.
Full textAbstract:
Abstract Background: Acesulfame-K (ACE), butylated hydroxytoluene (BHT), and aspartame (ASP) are a common combination of food additives added to chewing gums. The abuse of these additives results in severe adverse health effects; however, they are still extensively used owing to their high performance and low cost. Objective: The development and optimization of a simple, cheap, sensitive, and eco-friendly HPLC/UV method for the simultaneous determination of ASP, ACE, and BHT along with aspartame degradation product phenylalanine (PHEN) in chewing gum. Methods: The method was optimized using a 5 μm C18 column and an eluent consisting of methanol and 0.1 M phosphate buffer (pH 5.0) according to a suitable gradient elution program. Simple sample preparation, consisting of dilution, homogenization, and sonication followed by centrifugation and filtration, was optimized and used for the extraction of chewing gum. The greenness of the method was evaluated. Results: The proposed method exhibited excellent linearity (R2 > 0.9996), low LOQ (0.08–0.95 μg/mL), and recoveries between 85.3 and 98.83% with relative SD (RSD) ≤ 2.7%. High resolution was obtained with <25 min run times with excellent precision (RSD: 0.28–1.33%). This method was successfully applied for the simultaneous determination of ACE, ASP, and BHT in commercial chewing gum; PHEN was not detected. Furthermore, our method is considered to be environmentally acceptable. Conclusions: The results demonstrate that the developed method can be used to detect ACE, BHT, ASP, and PHEN in chewing gum. Highlights: A new sensitive, green HPLC/UV method is developed to be used as a minimal-cost routine analysis procedure for commercial chewing gum.
43
Shimoni, Yakhin, Don Hunt, Keyun Chen, Teresa Emmett, and Gary Kargacin. "Differential autocrine modulation of atrial and ventricular potassium currents and of oxidative stress in diabetic rats." American Journal of Physiology-Heart and Circulatory Physiology 290, no. 5 (May 2006): H1879—H1888. http://dx.doi.org/10.1152/ajpheart.01045.2005.
Full textAbstract:
The autocrine modulation of cardiac K+ currents was compared in ventricular and atrial cells (V and A cells, respectively) from Type 1 diabetic rats. K+ currents were measured by using whole cell voltage clamp. ANG II was measured by ELISA and immunofluorescent labeling. Oxidative stress was assessed by immunofluorescent labeling with dihydroethidium, a measure of superoxide ions. In V cells, K+ currents are attenuated after activation of the renin-angiotensin system (RAS) and the resulting ANG II-mediated oxidative stress. In striking contrast, these currents are not attenuated in A cells. Inhibition of the angiotensin-converting enzyme (ACE) also has no effect, in contrast to current augmentation in V cells. ANG II levels are enhanced in V, but not in A, cells. However, the high basal ANG II levels in A cells suggest that in these cells, ANG II-mediated pathways are suppressed, rather than ANG II formation. Concordantly, superoxide ion levels are lower in diabetic A than in V cells. Several findings indicate that high atrial natriuretic peptide (ANP) levels in A cells inhibit RAS activation. In male diabetic V cells, in vitro ANP (300 nM–1 μM, >5 h) decreases oxidative stress and augments K+ currents, but not when excess ANG II is present. ANP has no effect on ventricular K+ currents when the RAS is not activated, as in control males, in diabetic males treated with ACE inhibitor and in diabetic females. In conclusion, the modulation of K+ currents and oxidative stress is significantly different in A and V cells in diabetic rat hearts. The evidence suggests that this is largely due to inhibition of RAS activation and/or action by ANP in A cells. These results may underlie chamber-specific arrhythmogenic mechanisms.
44
Griffin, Debora, Kaley A. Walker, Ingo Wohltmann, Sandip S. Dhomse, Markus Rex, Martyn P. Chipperfield, Wuhu Feng, Gloria L. Manney, Jane Liu, and David Tarasick. "Stratospheric ozone loss in the Arctic winters between 2005 and 2013 derived with ACE-FTS measurements." Atmospheric Chemistry and Physics 19, no. 1 (January 16, 2019): 577–601. http://dx.doi.org/10.5194/acp-19-577-2019.
Full textAbstract:
Abstract. Stratospheric ozone loss inside the Arctic polar vortex for the winters between 2004–2005 and 2012–2013 has been quantified using measurements from the space-borne Atmospheric Chemistry Experiment Fourier Transform Spectrometer (ACE-FTS). For the first time, an evaluation has been performed of six different ozone loss estimation methods based on the same single observational dataset to determine the Arctic ozone loss (mixing ratio loss profiles and the partial-column ozone losses between 380 and 550 K). The methods used are the tracer-tracer correlation, the artificial tracer correlation, the average vortex profile descent, and the passive subtraction with model output from both Lagrangian and Eulerian chemical transport models (CTMs). For the tracer-tracer, the artificial tracer, and the average vortex profile descent approaches, various tracers have been used that are also measured by ACE-FTS. From these seven tracers investigated (CH4, N2O, HF, OCS, CFC-11, CFC-12, and CFC-113), we found that CH4, N2O, HF, and CFC-12 are the most suitable tracers for investigating polar stratospheric ozone depletion with ACE-FTS v3.5. The ozone loss estimates (in terms of the mixing ratio as well as total column ozone) are generally in good agreement between the different methods and among the different tracers. However, using the average vortex profile descent technique typically leads to smaller maximum losses (by approximately 15–30 DU) compared to all other methods. The passive subtraction method using output from CTMs generally results in slightly larger losses compared to the techniques that use ACE-FTS measurements only. The ozone loss computed, using both measurements and models, shows the greatest loss during the 2010–2011 Arctic winter. For that year, our results show that maximum ozone loss (2.1–2.7 ppmv) occurred at 460 K. The estimated partial-column ozone loss inside the polar vortex (between 380 and 550 K) using the different methods is 66–103, 61–95, 59–96, 41–89, and 85–122 DU for March 2005, 2007, 2008, 2010, and 2011, respectively. Ozone loss is difficult to diagnose for the Arctic winters during 2005–2006, 2008–2009, 2011–2012, and 2012–2013, because strong polar vortex disturbance or major sudden stratospheric warming events significantly perturbed the polar vortex, thereby limiting the number of measurements available for the analysis of ozone loss.
45
Ngoh Dooh, Jules Patrice, Josué Ngando Essoh, Serge Bertrand Mboussi, Alain Heu, William Norbert Kuate Tueguem, Dieudonne Amayana, Oscar Nguidjo, et al. "Thevetia peruviana (Pers.) K. Schum. Potential Antifungal Agent Against Mycosphaerella fijiensis Morelet, Fungi Responsible of Black Leaf Streak Disease (BLSD) of Plantain (Musa spp)." Journal of Agricultural Studies 9, no. 2 (April 22, 2021): 364. http://dx.doi.org/10.5296/jas.v9i2.18553.
Full textAbstract:
Alternatives to synthetic chemicals are undertaken against phytopathogens. The aim of this work is to evaluate the effect of seed extracts of Thevetia peruviana (Pers.) K. Schum. on Mycosphaerella fijiensis Morelet, fungus responsible for banana black leaf streak disease. Five extracts of T. peruviana, hexane extract (HE), ethyl acetate extract (EAE), acetone extract (AcE), methanol extract (ME) and aqueous extract (AqE), and a fungicide, Azoxystrobin were used. GC-MS of acetone extract was performed. Fifty (50) strains of M. fijiensis per sampling site were tested. Three concentrations of extracts 6.25 (C1), 12.5 (C2), and 25 (C3) μl/ml, a negative control (0 μl/ml) and 10 ppm of azoxystrobin were used for the tests. The MIC50 and MIC90 were determined. GC-MS showed chemical compounds with different molecular height such as acids, sugars, and esters. AcE and AqE significantly reduced M. fijiensis germ tube growth at C2 and C3 concentrations and with inhibition percentage respectively ranged of 60-90% and 40-80%. The growth levels of the germ tubes were above the strobilurin resistance threshold at Njombe and peasant plantation, ranging from 77.9% to 92.3%. AcE showed the same or superior efficacy as the fungicide used on conidial germination at all tested concentrations. The MIC50 totally reducing mycelial growth and conidial germination was 6.25 μl/ml. T. peruviana seeds extracts can be exploited in integrated pests management against M. fijiensis.
46
CRIPPA, M. "E001 Treatment of essential hypertension with hydrochlorothiazide combined with ACE-I or K+channel-I." American Journal of Hypertension 11, no. 4 (April 1998): 96A. http://dx.doi.org/10.1016/s0895-7061(97)91063-3.
Full text
47
Mirzaei, Mahta, Mahmoud Aminlari, and Ebrahim Hosseini. "Antioxidant, ACE-Inhibitory and Antimicrobial Activities of Kluyveromyces marxianus Protein Hydrolysates and Their Peptide Fractions." Functional Foods in Health and Disease 6, no. 7 (July 30, 2016): 425. http://dx.doi.org/10.31989/ffhd.v6i7.250.
Full textAbstract:
Background: There has been some evidence that proteins are potentially excellent source of antioxidants, antihypertensive and antimicrobial peptides and enzymatic hydrolysis is an effective method to release these peptides from protein molecules. The functional properties of protein hydrolysates depends on the protein substrate, the specificity of the enzymes, the conditions used during proteolysis, degree of hydrolysis, and the nature of peptides released including molecular weight, amino acid composition, and hydrophobicity.Context and purpose of this study: The biomass of Kluyveromyces marxianus was considered as a source of ACE inhibitory, antioxidant and antimicrobial peptides. Results: Autolysis and enzymatic hydrolysis were completed respectively, after 96 h and 5 h. Overall, trypsin (18.52% DH) and chymotrypsin (21.59% DH) treatments were successful in releasing antioxidant and ACE inhibitory peptides. Autolysate sample (39.51% DH) demonstrated a poor antioxidant and ACE inhibitory activity compared to trypsin and chymotrypsin hydrolysates. The chymotrypsin 3-5 kDa (301.6±22.81 μM TEAC/mg protein) and trypsin< 3 kDa (280.16±39.16) permeate peptide fractions showed the highest DPPH radical scavenging activity. The trypsin <3 kDa permeate peptide fraction showed the highest ABTS radical scavenging (1691.1±48.68 μMTE/mg protein) and ACE inhibitory (IC50=0.03±0.001 mg/ml) activities. The fraction (MW=5-10 kD) obtained after autolysis treatment showed antibacterial activity against St. aureus and Lis. monocytogenes in well diffusion screening. The minimum inhibitory concentration (MIC) value was 13.3 mg/ml against St. aureus and Lis. monocytogenes calculated by turbidimetric assay and it showed bactericidal activity against St. aureus at 21.3 mg/ml protein concentration. Conclusions: Taken together, the results of this study reveal that K. marxianus proteins contain specific peptides in their sequences which can be released by enzymatic hydrolysis and autolysis. Key words: Kluyveromyces marxianus; Antioxidant activity; ACE-inhibitory; Antimicrobial; Protein hydrolysate; Peptide
48
Chan, Catherine B., Zohre Hashemi, and Fatheema B. Subhan. "The impact of low and no-caloric sweeteners on glucose absorption, incretin secretion, and glucose tolerance." Applied Physiology, Nutrition, and Metabolism 42, no. 8 (August 2017): 793–801. http://dx.doi.org/10.1139/apnm-2016-0705.
Full textAbstract:
The consumption of non-nutritive, low, or no-calorie sweeteners (LCS) is increasing globally. Previously thought to be physiologically inert, there is a growing body of evidence that LCS not only provide a sweet taste but may also elicit metabolic effects in the gastrointestinal tract. This review provides a brief overview of the chemical and receptor-binding properties and effects on chemosensation of different LCS but focuses on the extent to which LCS stimulates glucose transport, incretin and insulin secretion, and effects on glucose tolerance. Aspartame and sucralose both bind to a similar region of the sweet receptor. For sucralose, the data are contradictory regarding effects on glucose tolerance in humans and may depend on the food or beverage matrix and the duration of administration, as suggested by longer term rodent studies. For aspartame, there are fewer data. On the other hand, acesulfame-potassium (Ace-K) and saccharin have similar binding characteristics to each other but, while Ace-K may increase incretin secretion and glucose responses in humans, there are no data on saccharin except in rats, which show impaired glucose tolerance after chronic administration. Additional research, particularly of the effects of chronic consumption, is needed to provide concrete evidence for beneficial or detrimental effects of LCS on blood glucose regulation in humans.
49
G.N., Rakhimova, and Sadikova A.S. "Genetic Determinism Of Chronic Kidney Disease By Ace Gene In Children And Adolescents Of The Uzbek Population With Type 1 Diabetes According To The K/Doqi Recommendation (2012)." American Journal of Medical Sciences and Pharmaceutical Research 03, no. 06 (June 10, 2021): 150–62. http://dx.doi.org/10.37547/tajmspr/volume03issue06-24.
Full textAbstract:
The study aimed to assess the functional state of the kidneys and to study the relationship of I/D polymorphism of the ACE gene with the stage of chronic kidney disease in children and adolescents of the Uzbek population with type 1 diabetes according to the new recommendations of K/DOQI (2012). We examined 120 children and adolescents with type 1 diabetes. Clinical, biochemical and genetic studies have been carried out. The study revealed that children with diabetes in the stage of compensation (НbА1с ≤7.5%) have CKD stages II (28.6%) and III (4.8%). The use of the new classification K/DOQI (2012) reveals a decrease in kidney function at earlier stages, in 61.9% of children and adolescents with type 1 diabetes, even at the NAU stage, a GFR of 80.6 ± 7.5 ml/min/1.73m2, which corresponds to stage II of CKD and 16.7% have a GFR of 45.1 ± 9.5 ml/min/1.73m2, which corresponds to stage III of CKD. Also, 28.6% of children and adolescents at the MAU stage have CKD II, 75.0% of CKD stage III, respectively. ACE I/D polymorphism is a molecular genetic marker of susceptibility to the development of CKD type 1 diabetes in children and adolescents.
50
Parrondo, Ricardo, Tracy Andrews, Rima M. Panchal, Sejal Kothadia, Camille Johnson, Jieqi Liu, Giselle Alexandra Suero-Abreu, David H. Vesole, David S. Siegel, and Noa Biran. "Carfilzomib Cardiovascular Disease: Use of the Atherosclerotic Cardiovascular Disease Score to Predict Cardiovascular Events in Multiple Myeloma Patients Treated with Carfilzomib." Blood 132, Supplement 1 (November 29, 2018): 3254. http://dx.doi.org/10.1182/blood-2018-99-113722.
Full textAbstract:
Abstract Introduction: In the ASPIRE and ENDEAVOR trials, multiple myeloma (MM) patients treated with carfilzomib (K) had significantly improved progression‐free survival and overall survival compared with standard of care. The incidence of all-grade adverse cardiovascular events (ACVE) was 26.6% and 24.5% in the K treated groups in ASPIRE and ENDEAVOR respectively. The atherosclerotic cardiovascular disease (ASCVD) score is a risk stratification tool used by cardiologists to classify patients with a score ≥7.5% as high risk for the incidence of ASCVD events. To date, there are no clinically relevant models that predict the likelihood of ACVE in MM patients treated with K nor are we aware of any protective factors against ACVE. Our study aims to identify factors which can predict and mitigate the incidence of ACVE. Methods: A retrospective chart review of 372 MM patients who were treated with K between 2011 and 2018 at our institution was performed.Data were summarized using descriptive statistics; Chi-square tests of association and Kruskal-Wallis tests were employed to test for differences across groups, where appropriate. Logistic regression was performed to examine the risk factors associated with ACVE. Results: Of the 372 patients, 243 (65%) were Durie-Salmon Stage (DSS) III, 70 (19%) were International Staging System (ISS) III; 186 (50%) were men. There were a total of 102 (27%) ACVE and 33 (9%) ≥grade 3 events. The most common ACVE were congestive heart failure (29%), asymptomatic elevations in pulmonary arterial systolic pressure (PASP) (27%), and hypertension (HTN) (16%). Sixty-eight (66%) Caucasians, 14 (14%) African Americans and 17 (17%) Hispanics developed ACVE. Aspirin (ASA) (64%), beta blockers (BB) (51%), calcium channel blockers (CCB) (43%) and statins (37%) were the most common cardiac medications patients were taking at the time of K initiation. Regardless of cardiac history, patients who were taking a CCB had higher odds of experiencing an ACVE compared to patients who were not taking a CCB (CCB + Cardiac history: OR=1.9; CI=1.0-3.7; CCB, no Cardiac history: OR=6.3; CI= 2.1-18.4) (Table 1). Patients with an ASCVD score ≥7.5% did not have an increased incidence of ACVE but did have an increased incidence of ≥grade 3 vs. grade 1-2 ACVE (100% vs. 78%, p=0.092). Prior cardiac history, including history of HTN, was common (59%) but not associated with incidence or severity of ACVE. Those with type 2 diabetes had a higher rate of ≥grade 3 vs. grade 1-2 ACVE (33% vs. 10%, p=0.004). Patients on certain CV medications while receiving K-based treatment had a higher incidence of ACVE compared to those not on these medications, including BB (51% vs. 34%, p=0.002), CCB (43% vs. 26%, p=0.002), aldosterone antagonists (AA) (8% vs. 3%, p=0.024) and statins (37% vs. 25%, p=0.022). Patients on ASA were more likely to experience ≥grade 3 compared to grade 1-2 ACVE (78% vs. 53%, p=0.016). ACE inhibitors or angiotensin receptor blockers (ACE/ARB) were not associated with increased incidence or severity of ACVE. The use of K in relapsed, as opposed to induction setting, was associated with a higher incidence of ACVE (31% vs. 20%, p=0.035). Maximum dose and number of K doses were not associated with ACVE. There was no relationship between PASP elevation and age >75, use of BB, CCB, AA, ACE/ARB, number of K treatments or maximum dose of K. Factors that were associated with increased odds of ACVE in multivariate analysis included patients who received K in the relapsed setting (OR= 1.7; CI=0.94-3.0) and use of an AA (OR= 4.5; CI=1.4-14.1) (Table 1). Conclusion: In line with prior studies, 28% of MM patients treated with K at our institution developed an ACVE, with 9% grade 3 or above. Use of CCB and AA were particularly associated with increased risk of ACVE, while use of ACE/ARB were not. ASCVD score ≥7.5% was associated with an increased incidence of ≥grade 3 ACVE in K-treated patients and should perhaps be evaluated as a predictive tool in prospective studies. Disclosures Siegel: Celgene: Consultancy, Honoraria, Research Funding, Speakers Bureau; Janssen: Consultancy, Honoraria, Speakers Bureau; Takeda: Consultancy, Honoraria, Speakers Bureau; Novartis: Honoraria, Speakers Bureau; Amgen: Consultancy, Honoraria, Speakers Bureau; BMS: Consultancy, Honoraria, Speakers Bureau; Karyopharm: Consultancy, Honoraria; Merck: Consultancy, Honoraria, Speakers Bureau. Biran:Merck: Research Funding; Amgen: Consultancy, Speakers Bureau; Takeda: Consultancy, Speakers Bureau; Celgene: Consultancy, Honoraria, Speakers Bureau; BMS: Research Funding.